New method for assessing the structural changes in cardiac arrhythmia

FHS
August 4, 2023
10:46 am

A multidisciplinary study led by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) presents a new method for assessing the structural and electrophysiological changes, called atrial remodeling, produced in the heart of patients with atrial fibrillation, one of the most frequent forms of cardiac arrhythmia.

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Conference 20.09.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

September 21, 2023

Sanofi sues Sarepta, alleging that Duchenne treatment Elevidys infringes on AAV patents

Sanofi is suing Sarepta Therapeutics, alleging that the company’s approved muscular dystrophy treatment infringes on its patents related to the chemical makeup of the product

August 1, 2024

iOnctura raises nearly $86m in Series B to fund Phase II cancer trials

Syncona was the major investor in iOnctura having invested €30m ($32.2m) for a 23% stake in the company. Image Credit: eamesBot / Shutterstock. Swiss biopharma

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.